Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000185372
Created by
admin on Fri Dec 15 20:12:41 GMT 2023 , Edited by admin on Fri Dec 15 20:12:41 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
892338
Created by
admin on Fri Dec 15 20:12:41 GMT 2023 , Edited by admin on Fri Dec 15 20:12:41 GMT 2023
|
PRIMARY | RxNorm | ||
|
N0000171131
Created by
admin on Fri Dec 15 20:12:41 GMT 2023 , Edited by admin on Fri Dec 15 20:12:41 GMT 2023
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
N0000185001
Created by
admin on Fri Dec 15 20:12:41 GMT 2023 , Edited by admin on Fri Dec 15 20:12:41 GMT 2023
|
PRIMARY | Increased IgG Production [PE] | ||
|
DB10581
Created by
admin on Fri Dec 15 20:12:41 GMT 2023 , Edited by admin on Fri Dec 15 20:12:41 GMT 2023
|
PRIMARY | |||
|
114231
Created by
admin on Fri Dec 15 20:12:41 GMT 2023 , Edited by admin on Fri Dec 15 20:12:41 GMT 2023
|
PRIMARY | |||
|
VK8C112WTS
Created by
admin on Fri Dec 15 20:12:41 GMT 2023 , Edited by admin on Fri Dec 15 20:12:41 GMT 2023
|
PRIMARY | |||
|
VK8C112WTS
Created by
admin on Fri Dec 15 20:12:41 GMT 2023 , Edited by admin on Fri Dec 15 20:12:41 GMT 2023
|
PRIMARY | |||
|
N0000175629
Created by
admin on Fri Dec 15 20:12:41 GMT 2023 , Edited by admin on Fri Dec 15 20:12:41 GMT 2023
|
PRIMARY | Increased Histamine Release [PE] | ||
|
N0000169106
Created by
admin on Fri Dec 15 20:12:41 GMT 2023 , Edited by admin on Fri Dec 15 20:12:41 GMT 2023
|
PRIMARY | Fungal Proteins [Chemical/Ingredient] | ||
|
N0000184306
Created by
admin on Fri Dec 15 20:12:41 GMT 2023 , Edited by admin on Fri Dec 15 20:12:41 GMT 2023
|
PRIMARY | Cell-mediated Immunity [PE] |
ACTIVE MOIETY